Personalized Pacing: A New Paradigm for Patients With Diastolic Dysfunction or Heart Failure With Preserved Ejection Fraction
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 123 participants.
Also called NCT04721314
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 123 participants
- Sponsor
- Registry
-
NCT04721314
-
- Other papers using this trial's data
- Effect of Personalized Accelerated Pacing on Quality of Life, Physical Activity, and Atrial Fibrillation in Patients With Preclinical and Overt Heart Failure With Preserved Ejection Fraction: The myPACE Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT04721314. Randomized; double masking; primary purpose treatment. Start 2019-07-17 (actual); primary completion 2021-10-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Personalized Pacing: A New Paradigm for Patients With Diastolic Dysfunction or Heart Failure With Preserved Ejection Fraction
- Acronym
- myPACE
- Condition
- Pacemaker
- Condition
- Diastolic Dysfunction
- Condition
- Diastolic Heart Failure
- Intervention (Device)
- Adjustment of lower rate limit
- Intervention (Device)
- Maintenance of lower rate limit
- Lead sponsor
- University of Vermont
Record details
- Record id
cardio:ct-nct04721314- Content hash
754a9092b18c3e5219e6d121c102d767886702c684117d82004a46b76623bcc3